Next Article in Journal
Fracture Resistance of New Metal-Free Materials Used for CAD-CAM Fabrication of Partial Posterior Restorations
Previous Article in Journal
Impact of Elderly Masticatory Performance on Nutritional Status: An Observational Study
Open AccessArticle

Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties

1
Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany
2
Veterinary Science (Theriogenology), Agriculture and Forestry University (AFU), Center for Biotechnology, 44209 Rampur, Chitwan, Nepal
3
Department of Pulmonology, Sechenov First Moscow State Medical University (Sechenov University), 119992 Moscow, Russia
*
Authors to whom correspondence should be addressed.
Medicina 2020, 56(3), 131; https://doi.org/10.3390/medicina56030131
Received: 25 February 2020 / Revised: 12 March 2020 / Accepted: 13 March 2020 / Published: 16 March 2020
Background and objectives: Pulmonary hypertension (PH) is characterized by the vasoconstriction and abnormally proliferative vascular cells. The available allopathic treatment options for PH are still not able to cure the disease. Alternative medicine is becoming popular and drawing the attention of the general public and scientific communities. The entomogenous fungus Yarsagumba (Cordyceps sinensis) and its biologically active ingredient cordycepin may represent the therapeutic option for this incurable disease, owing to their anti-inflammatory, vasodilatory and anti-oxidative effects. Methods: In this study, we investigated whether Yarsagumba extract and cordycepin possess anti-proliferative and vasorelaxant properties in the context of PH, using 5-bromo-2’-deoxyuridine assay and isolated mice lungs, respectively. Results: Our results revealed that Yarsagumba extract and its bioactive compound cordycepin significantly attenuated the proliferation of human pulmonary artery smooth muscle cells derived from donor and PH subjects. In isolated murine lungs, only Yarsagumba extract, but not cordycepin, resulted in vasodilatation, indicating the probable existence of other bioactive metabolites present in Yarsagumba that may be responsible for this outcome. Conclusion: Future comprehensive in vivo and in vitro research is crucially needed to discover the profound mechanistic insights with regard to this promising therapeutic potency of Yarsagumba extract and to provide further evidence as to whether it can be used as a strategy for the treatment of PH. View Full-Text
Keywords: Yarsagumba; cordycepin; pulmonary hypertension; pulmonary vascular smooth muscle cells; pulmonary vasodilatation; biomaterial Yarsagumba; cordycepin; pulmonary hypertension; pulmonary vascular smooth muscle cells; pulmonary vasodilatation; biomaterial
Show Figures

Graphical abstract

MDPI and ACS Style

Luitel, H.; Novoyatleva, T.; Sydykov, A.; Petrovic, A.; Mamazhakypov, A.; Devkota, B.; Wygrecka, M.; Ghofrani, H.A.; Avdeev, S.; Schermuly, R.T.; Kosanovic, D. Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties. Medicina 2020, 56, 131.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop